Deep Tech Opportunities Report
Company Profile
Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits
Thoughts
Human identity needs a Zero Trust moment
Company Profile
Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners
Q&A
Reality Defender democratizes deepfake detection with public API launch
Thoughts
Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership
Q&A
Reality Defender answers FINRA call
Deep Tech Opportunities Report
DCVC DTOR 2024: Startup thinking will help the defense and security sectors prepare for new threats
News
Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration
News
Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs
Snapshot
Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells
News
Quantum Advantage: Q-CTRL’s next-generation navigation system to guide us when GPS can’t
News
Proprio’s latest FDA approval clears the way for better, AI-driven surgery
DCVC Announcements
24
In The Media
363
Reuters
Cow tech startup becomes New Zealand's latest unicorn in $100 million fundraise
Halter
Wall Street Journal
Morgan Stanley Backs Insight M, a Methane-Detecting Services Provider
Insight M
Heatmap News
Radiant Nuclear Is Aiming to Build Microreactors ASAP [Rachel Slaybaugh featured]
Radiant
Wall Street Journal
Bill Gates Is Backing This Geothermal Company. Will Trump’s Republicans?
Fervo Energy
2025 Deep Tech Opportunities Report
DCVC’s partners share their thoughts on the most compelling areas of prospective deep tech investment in 2025 and beyond.